We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close


Will Big Drugmakers Mimic Purdue On Opioid Marketing?

Law360 (February 12, 2018, 9:50 PM EST) -- Purdue Pharma’s decision to scale back its opioid marketing amid an onslaught of litigation will force many big drugmakers to consider similar moves, potentially marking a seminal moment in the nation’s brutal opioid epidemic.

Purdue announced over the weekend that it cut its sales force in half and stopped sending opioid promoters to physician offices "effective immediately." The decision comes as Purdue and other opioid sellers are embroiled in multidistrict litigation in Ohio federal court, where U.S. District Judge Dan Polster is hoping for a quick...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.